CONMED Return on Tangible Equity 2010-2024 | CNMD

Current and historical return on tangible equity values for CONMED (CNMD) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
CONMED Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-06-30 $0.10B $-0.56B -16.17%
2024-03-31 $0.08B $-0.59B -12.81%
2023-12-31 $0.07B $-0.62B -9.50%
2023-09-30 $0.06B $-0.68B -8.23%
2023-06-30 $0.09B $-0.70B -11.96%
2023-03-31 $-0.09B $-0.74B 12.92%
2022-12-31 $-0.08B $-0.75B 13.15%
2022-09-30 $-0.08B $-0.79B 16.73%
2022-06-30 $-0.11B $-0.60B 29.65%
2022-03-31 $0.07B $-0.29B -20.69%
2021-12-31 $0.06B $-0.30B -17.84%
2021-09-30 $0.06B $-0.34B -16.56%
2021-06-30 $0.05B $-0.36B -13.49%
2021-03-31 $0.01B $-0.39B -3.29%
2020-12-31 $0.01B $-0.41B -2.28%
2020-09-30 $0.00B $-0.44B -0.22%
2020-06-30 $0.00B $-0.46B -0.22%
2020-03-31 $0.03B $-0.44B -7.61%
2019-12-31 $0.03B $-0.44B -6.38%
2019-09-30 $0.03B $-0.45B -7.85%
2019-06-30 $0.03B $-0.46B -9.34%
2019-03-31 $0.03B $-0.47B -13.24%
2018-12-31 $0.04B $-0.15B -24.82%
2018-09-30 $0.07B $-0.16B -41.07%
2018-06-30 $0.07B $-0.18B -38.05%
2018-03-31 $0.07B $-0.18B -34.42%
2017-12-31 $0.06B $-0.19B -24.92%
2017-09-30 $0.02B $-0.23B -6.42%
2017-06-30 $0.02B $-0.23B -6.37%
2017-03-31 $0.01B $-0.24B -5.01%
2016-12-31 $0.02B $-0.24B -6.17%
2016-09-30 $0.02B $-0.24B -8.90%
2016-06-30 $0.02B $-0.25B -15.25%
2016-03-31 $0.02B $-0.25B -40.18%
2015-12-31 $0.03B $0.02B 333.33%
2015-09-30 $0.03B $0.01B 455.17%
2015-06-30 $0.03B $0.01B 281.08%
2015-03-31 $0.03B $0.01B 161.11%
2014-12-31 $0.03B $0.01B 130.61%
2014-09-30 $0.03B $0.02B 97.64%
2014-06-30 $0.04B $0.04B 106.87%
2014-03-31 $0.04B $0.03B 58.58%
2013-12-31 $0.04B $0.04B 39.13%
2013-09-30 $0.04B $0.02B 41.81%
2013-06-30 $0.04B $0.15B 32.92%
2013-03-31 $0.04B $0.16B 31.75%
2012-12-31 $0.04B $0.02B 31.87%
2012-09-30 $0.00B $0.15B 2.58%
2012-06-30 $0.00B $0.17B 2.01%
2012-03-31 $0.00B $0.16B 1.42%
2011-12-31 $0.00B $0.14B 0.76%
2011-09-30 $0.03B $0.13B 27.33%
2011-06-30 $0.03B $0.14B 30.43%
2011-03-31 $0.03B $0.12B 31.84%
2010-12-31 $0.03B $0.10B 31.66%
2010-09-30 $0.03B $0.09B 30.03%
2010-06-30 $0.02B $0.09B 21.74%
2010-03-31 $0.01B $0.10B 15.64%
2009-12-31 $0.01B $0.10B 13.21%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.337B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Becton Dickinson (BDX) United States $69.388B 18.80
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
Merit Medical Systems (MMSI) United States $5.972B 30.50
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Lifevantage (LFVN) United States $0.175B 23.23
Pro-Dex (PDEX) United States $0.140B 27.95